BBIO icon

BridgeBio Pharma

178 hedge funds and large institutions have $1.45B invested in BridgeBio Pharma in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 49 increasing their positions, 59 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

25% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 57

39% less capital invested

Capital invested by funds: $2.37B → $1.45B (-$913M)

Holders
178
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.2M
Puts
$4.17M
Net Calls
Net Calls Change

Top Buyers

1 +$57.7M
2 +$12.4M
3 +$12.3M
4
Morgan Stanley
Morgan Stanley
New York
+$7.74M
5
LCM
Laurion Capital Management
New York
+$7.06M

Top Sellers

1 -$33.4M
2 -$16.7M
3 -$12.7M
4
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$10.3M
5
AAA
Affinity Asset Advisors
New York
-$8.24M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$315M
2
$270M
3
$95.7M
4
$93.4M
5
$92.8M
6
$61.6M
7
$54.4M
8
$39M
9
$37.8M
10
$25.3M
11
$23M
12
$18.9M
13
$18.1M
14
$15.9M
15
$12.5M
16
$11.7M
17
$11.5M
18
$11.5M
19
$11.5M
20
$11.1M
21
$11M
22
$10.1M
23
$9.92M
24
$9.32M
25
$8.58M